Alopecia Universalis as a Side Effect of Pegylated Interferon α-Ribavirin Combination Therapy for Hepatitis C: A Rare Case Report

    October 2016 in “ Journal of Chemotherapy ”
    Poonam Verma, Surabhi Dayal, Vijay Kumar Jain, A. Amrani
    Studysummary This case report describes a rare instance of alopecia universalis occurring eight weeks after discontinuing pegylated interferon α and ribavirin therapy, highlighting the need for awareness among healthcare providers.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Alopecia Universalis After Discontinuation of Pegylated Interferon and Ribavirin Combination Therapy for Hepatitis C: A Case Report Annals of Hepatology · 2014
    2. Alopecia Areata: An Update Indian Journal of Dermatology, Venereology and Leprology · 2013
    3. Alopecia Areata Update Journal of The American Academy of Dermatology · 2010
    4. A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin Canadian Journal of Gastroenterology · 2009
    5. Reversible Alopecia Universalis Secondary to PEG-Interferon Alpha-2b and Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection European Journal of Gastroenterology & Hepatology · 2007
    6. Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C Journal of Chemotherapy · 2005
    7. Alopecia Areata During Interferon Alpha-2b and Ribavirin Therapy Dermatology · 2002

    Related research 3

    1. Alopecia Universalis as a Side Effect of Pegylated Interferon α-Ribavirin Combination Therapy for Hepatitis C: A Rare Case Report Journal of Chemotherapy · 2016
    2. Alopecia Universalis After Discontinuation of Pegylated Interferon and Ribavirin Combination Therapy for Hepatitis C: A Case Report Annals of Hepatology · 2014
    3. Reversible Alopecia Universalis Secondary to PEG-Interferon Alpha-2b and Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection European Journal of Gastroenterology & Hepatology · 2007